ask="8.50"
ask_size="500"
average_daily_volume="352385"
bid="N/A"
bid_size="N/A"
book_value="3.69"
change="+0.20"
change_from_200_day_moving_average="-3.44"
change_from_50_day_moving_average="-1.97"
change_from_52_week_high="-7.55"
change_From_52_week_low="2.99"
change_in_percent="+2.92%"
close="7.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="16063000"
high="7.15"
high_52_weeks="14.60"
last_trade_date="2/27/2017"
last_trade_price="7.05"
last_trade_size="11268"
last_trade_time="4:00pm"
low="6.75"
low_52_weeks="4.06"
market_capitalization="125.81M"
moving_average_200_day="10.49"
moving_average_50_day="9.02"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="7.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-32.83%"
percent_change_from_50_day_moving_average="-21.88%"
percent_change_from_52_week_high="-51.71%"
percent_change_from_52_week_low="+73.69%"
previous_close="6.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.86"
price_per_sales="129.00"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.96"
stock_exchange="NCM"
symbol="STML"
volume="565241"
weeks_range_52="4.06 - 14.60"
